An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk
(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6
Read More